Behind the Science
If 400m+ people live with COPD, why aren’t we talking about it?
In the latest Behind the Science podcast, Dr. Kat Arney, Prof. Dave Singh and Dr. Kaivan Khavandi explore how COPD affects everyday life and why severe exacerbations, or attacks, can have such serious consequences on those living with the condition.
Who we are
As a focused biopharma company, we discover, develop and deliver medicines and vaccines to create value for patients and shareholders. We aim to positively impact the health of 2.5 billion people by the end of the decade.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
Behind the Science
